When medicine evolves, so do the methods of administration, supply chain processes, and technology used to connect patients to the therapies they need. And because a rapidly changing cell and gene therapy industry requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that bring these cutting-edge therapies to market.
Let’s build the future together.
Working together to alleviate barriers
Together, our businesses provide:
Expert guidance on reimbursement and policy utilizing different modeling and information exchange
Complete logistics support from pre-clinical, through clinical trials to commercialization and post-launch solutions
Purchasing and business optimization for thousands of health systems, community practices, independent pharmacies and alternate care settings
Innovative patient access, affordability and adherence solutions
Redefining moments that matter
We approach every touchpoint along the cell and gene therapy commercialization and treatment timeline with the patient in mind. When we all collaborate to deliver potentially life-saving solutions, we can start redefining the moments that matter for patients, clinicians and our key stakeholders.